145 related articles for article (PubMed ID: 24112388)
21. Redox proteomics reveal stress responsive proteins linking peroxiredoxin-1 status in glioma to chemosensitivity and oxidative stress.
Poschmann G; Grzendowski M; Stefanski A; Bruns E; Meyer HE; Stühler K
Biochim Biophys Acta; 2015 Jun; 1854(6):624-31. PubMed ID: 25484280
[TBL] [Abstract][Full Text] [Related]
22. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.
Nakajima S; Doi R; Toyoda E; Tsuji S; Wada M; Koizumi M; Tulachan SS; Ito D; Kami K; Mori T; Kawaguchi Y; Fujimoto K; Hosotani R; Imamura M
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4125-33. PubMed ID: 15217949
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells.
Horvath Z; Bauer W; Hoechtl T; Saiko P; Fritzer-Szekeres M; Tihan T; Szekeres T
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1531-5. PubMed ID: 15571292
[TBL] [Abstract][Full Text] [Related]
24. Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes.
Harada K; Ferdous T; Ueyama Y
Int J Oncol; 2014 Apr; 44(4):1302-8. PubMed ID: 24452635
[TBL] [Abstract][Full Text] [Related]
25. Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Hank NC; Shapiro JR; Scheck AC
BMC Cancer; 2006 Jan; 6():2. PubMed ID: 16393339
[TBL] [Abstract][Full Text] [Related]
26. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
[TBL] [Abstract][Full Text] [Related]
27. Exendin-4 inhibits glioma cell migration, invasion and epithelial-to-mesenchymal transition through GLP-1R/sirt3 pathway.
Nie ZJ; Zhang YG; Chang YH; Li QY; Zhang YL
Biomed Pharmacother; 2018 Oct; 106():1364-1369. PubMed ID: 30119208
[TBL] [Abstract][Full Text] [Related]
28. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
29. Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling.
Rhee CH; Ruan S; Chen S; Chenchik A; Levin VA; Yung AW; Fuller GN; Zhang W
Oncol Rep; 1999; 6(2):393-401. PubMed ID: 10023010
[TBL] [Abstract][Full Text] [Related]
30. Altered nuclear localization of bax protein in BCNU-resistant glioma cells.
Joy A; Panicker S; Shapiro JR
J Neurooncol; 2000 Sep; 49(2):117-29. PubMed ID: 11206007
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione.
Yang DI; Yin JH; Ju TC; Chen LS; Hsu CY
Free Radic Biol Med; 2004 May; 36(10):1317-28. PubMed ID: 15110396
[TBL] [Abstract][Full Text] [Related]
32. Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas.
Simon M; Voss D; Park-Simon TW; Mahlberg R; Köster G
Oncol Rep; 2006 Jul; 16(1):127-32. PubMed ID: 16786135
[TBL] [Abstract][Full Text] [Related]
33. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.
Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080
[TBL] [Abstract][Full Text] [Related]
34. Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype.
Cervantes-Arias A; Pang LY; Argyle DJ
Vet Comp Oncol; 2013 Sep; 11(3):169-84. PubMed ID: 22404947
[TBL] [Abstract][Full Text] [Related]
35. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
[TBL] [Abstract][Full Text] [Related]
36. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.
Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH
Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells.
Sukumari-Ramesh S; Prasad N; Alleyne CH; Vender JR; Dhandapani KM
BMC Cancer; 2015 Mar; 15():118. PubMed ID: 25851054
[TBL] [Abstract][Full Text] [Related]
38. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
40. SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell.
Liu H; Gu Y; Yin J; Zheng G; Wang C; Zhang Z; Deng M; Liu J; Jia X; He Z
Cell Signal; 2014 Dec; 26(12):2710-20. PubMed ID: 25152373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
